Oral-Fluid Cannabis Testing Needs a Defined Program Purpose Before a Cutoff Is Chosen

A review of oral-fluid cannabinoids emphasized that testing programs need collection, analysis, storage and cutoff criteria tailored to their purpose. A threshold designed to detect exposure cannot automatically serve as a threshold for impairment.

Different cannabinoids have different profiles

The review brought together controlled administration and field studies, describing distinct concentration ranges, elimination patterns and detection windows for parent cannabinoids and metabolites. A result should identify the analyte actually measured rather than treating all cannabinoid findings as equivalent.

A cutoff is part of the testing system

Route, dose and use history can influence oral-fluid findings. Collection and analytical procedures also belong in the interpretation. Selecting a number without specifying these conditions does not create a reproducible program, even if another laboratory uses the same numerical threshold.

The program's objective limits the conclusion

Monitoring exposure, investigating an event and assessing functional capacity are different objectives. The review considered correlations with blood and impairment, but a correlation across samples does not establish an individual impairment rule. Its emphasis on program design is particularly useful when comparing results from unlike testing settings.

Interpreting the evidence

A meaningful test description states the purpose, specimen, analyte, collection method and decision threshold together. This historical synthesis supplies that framework. It does not establish a universal detection window, an exposure-to-impairment conversion or a cutoff appropriate for every workplace and forensic question.

Related reading: interpreting cannabis tolerance claims.

Research reference

Dayong Lee; Marilyn A. Huestis (2013). Current Knowledge on Cannabinoids in Oral Fluid. Drug testing and analysis. doi:10.1002/dta.1514.

This discussion draws on the abstract and introductory material in the supplied research synthesis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC. The preparation isolated a mechanistic question Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed…

Spread the love

Read Article: An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A 1999 isolated guinea-pig intestinal-tissue experiment found bidirectional cross-tolerance between morphine and WIN 55,212-2. Yet antagonist-triggered contraction did not appear symmetrically, limiting a simple claim that the two dependence states were identical. The model measured tissue responses Myenteric-plexus longitudinal-muscle preparations were incubated with the compounds and tested through electrically evoked…

Spread the love

Read Article: An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

A 1998 mouse study used a CB1 antagonist to precipitate withdrawal after repeated THC. Its behavioral findings support an experimental dependence model, while remaining different from the natural course of human cannabis withdrawal. The trigger was an administered antagonist After repeated THC, antagonist challenge promptly increased paw tremors and head…

Spread the love

Read Article: A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us